glp-1 long term studies Meta Monday! WEIGHT REGAIN AFTER STOPPING MEDICATIONS: https://www.medscape.com/viewarticle/less-weight-regain-more-health-loss-after-stopping- glp-1s-2026a10006rv?ecd=a2a&form=fpf A recent study highlighted an important reality about GLP-1 The transformative breakthroughs in GLP-1

Ha, Carbon nanotubes: an effective platform for biomedical electronics

Why Inflammation Matters on GLP-1s Chronic inflammation is closely tied to: Insulin resistance Weight gain and fat storage Hormonal imbalance Digestive discomfort Slower metabolic response GLP-1 medications help regulate appetite and blood sugar, but ongoing inflammation can blunt their effectiveness

Sarlo K & Clark ED (1992) A tier approach for evaluating the respiratory allergenicity of low molecular weight chemicals

2.2.1 TGF- TGF- is the most potent pro-fibrotic mediator, inducing ECM, EMT, and pro-fibrotic mediators production by promoting the binding of Smad2/3 to Smad4, and driving myofibroblast differentiation to promote the PF process (Hu et al., 2018